RxDoctor Payments Data

Stephen Kayiaros, MD

Orthopaedic Surgery · Princeton, NJNPI 1669699542

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $25,451 of the $30,645 with a category attached, or 83.1%. 15 manufacturers reported payments, led by Omnilife Science, Inc at 38.3% of the total. Reporting peaked in 2019 at $11,290 and has fallen 64.2% since, to $4,036 in 2025.

$30,645in general payments, 2019–2025

Across 92 payments — averaging $333.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Omnilife Science, Inc$12K
  • Depuy Synthes Products, Inc.$6K
  • Medical Device Business Services, Inc.$5K
  • Corin USA$5K
  • Stryker$1K
  • Johnson & Johnson$733
  • plus $1K from 9 others
$18,677in research payments, 2019–2025

Across 6 payments — averaging $3112.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$19K

What the payments were for

  • Consulting fees$25,45183%
  • Travel & lodging$1,3504%
  • Food & beverage$3,84313%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,645 in reported general payments places this provider in the 85th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey →

Medicare billing

Part B allowed, 2024
$500,985
Medicare patients
695
Services billed
5,103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib188$5,692
Meloxicam119$404
Methylprednisolone49$249
Oxycodone Hcl38$172
Tramadol Hcl46$145
Gabapentin15$143
Dexamethasone21$116
Amoxicillin26$31

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Princeton

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →